Abstract
Background: Vaccines are the most reliable alternative to elicit sterile immunity against malaria but their development has been hindered by polymorphisms and strain-specificity in previously studied antigens. New vaccine candidates are therefore urgently needed. Highly conserved Plasmodium falciparum reticulocyte binding protein homologue-5 (PfRH5) has been identified as a potential candidate for anti-disease vaccine development. PfRH5 is essential for erythrocyte invasion by merozoites and crucial for parasite survival. However, there is paucity of data on the extent of genetic variations on PfRH5 in field isolates of Plasmodium falciparum.
[mks_button size=”large” title=”Download PDF” style=”squared” url=”https://clinicalhealthjournal.com/wp-content/uploads/2020/09/Genetic-polymorphisms-in-malaria-vaccine-candidate-1.pdf” target=”_self” bg_color=”#000000″ txt_color=”#FFFFFF” icon=”” icon_type=”” nofollow=”0″]
Genetic-polymorphisms-in-malaria-vaccine-candidate-1